Oracle Investment Management as of Dec. 31, 2015
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 23 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Accelr8 Technology Corporation | 21.0 | $121M | 5.6M | 21.49 | |
| NxStage Medical | 12.5 | $72M | 3.3M | 21.91 | |
| Quidel Corporation | 10.3 | $59M | 2.8M | 21.20 | |
| Pacific Biosciences of California (PACB) | 8.3 | $48M | 3.7M | 13.13 | |
| Opko Health (OPK) | 6.8 | $39M | 3.9M | 10.05 | |
| Acorda Therapeutics | 6.0 | $35M | 816k | 42.78 | |
| Mazor Robotics Ltd. equities | 5.0 | $29M | 2.8M | 10.16 | |
| Tesaro | 4.9 | $28M | 541k | 52.32 | |
| Intrexon | 4.9 | $28M | 933k | 30.15 | |
| Accuray Incorporated (ARAY) | 3.4 | $20M | 2.9M | 6.75 | |
| Vermillion | 2.7 | $16M | 8.6M | 1.80 | |
| shares Agenus | 2.2 | $13M | 2.9M | 4.54 | |
| Amarin Corporation (AMRN) | 2.2 | $13M | 6.6M | 1.89 | |
| WebMD Health | 2.0 | $12M | 238k | 48.30 | |
| Hansen Medical | 1.8 | $11M | 4.5M | 2.33 | |
| Biolase Technology | 1.5 | $8.8M | 11M | 0.84 | |
| Transition Therapeutics | 1.3 | $7.5M | 3.9M | 1.92 | |
| Chimerix (CMRX) | 1.1 | $6.6M | 736k | 8.95 | |
| Contrafect | 1.0 | $5.6M | 1.2M | 4.75 | |
| Biogen Idec (BIIB) | 0.4 | $2.4M | 7.7k | 306.36 | |
| Metabolix | 0.2 | $1.4M | 934k | 1.54 | |
| Second Sight Med Prods | 0.2 | $1.2M | 203k | 5.89 | |
| ZIOPHARM Oncology | 0.2 | $1.1M | 132k | 8.31 |
